All University of Tennessee articles
-
News
Multi-disciplinary team awarded $3.9 million to study mixed fungal-bacterial infections
A multi-disciplinary team was recently awarded $3.9 million from the National Institute of Allergy and Infectious Diseases for a project aimed at unravelling intricate mysteries surrounding complex fungal-bacterial infections.
-
News
Researchers awarded $308k grant to study the role of gut microbiomes to improve outcomes in dystonia
Scientists are undertaking a study that will investigate the role of the gut microbiome in dystonia, a movement disorder of abnormal postures and involuntary twisting or repetitive movements, to improve neurobehavioral outcomes.
-
News
U-M lands $6.5 million center to study links between Great Lakes algal blooms, human health
Great Lakes researchers at the University of Michigan have been awarded a $6.5 million, five-year federal grant to host a center for the study of links between climate change, harmful algal blooms and human health.
-
News
Scientists ID new genus of fungi on grasses
This study examined a mushroom species, Campanella subdendrophora, also known as Tetrapyrgos subdendrophora, which fruits on grasses in the US Pacific Northwest, and determined that a new genus, Metacampanella was needed for this taxon.
-
News
Pathogens use force to breach immune defenses, study finds
Researchers have discovered a previously unknown process by which pathogens enter a cell with physical force, breaching the body’s immune defenses that prevent infection.
-
News
Researchers receive $423,500 for study to improve outcomes from fungal infections
Researchers have received a $423,500 for research aimed at reducing disease and mortality rates associated with Aspergillus infections by focusing on the molecular pathways in the fungus that mediate inflammatory host responses.
-
News
Team designs molecule to disrupt SARS-CoV-2 infection mechanism
A team of scientists led by the Department of Energy’s Oak Ridge National Laboratory has designed a molecule that disrupts the infection mechanism of the SARS-CoV-2 coronavirus and could be used to develop new treatments for COVID-19 and other viral diseases.